Re:HPV vaccination reduces oncogenic HPV16/18 prevalence fro...
by miroljub on Saturday January 03, 2026 @06:11AM
(#46475281)
It's not bad per se, but the cost benefit analysis looks different due to different risk profile.
[ Parent
| on HN ]
There are no comments on this comment yet.